MarketCap
Facebook
X
TelegramQuarterly report 2025-Q3
added 11-05-2025
Zimmer Biomet Holdings Market Cap 2011-2026 | ZBH
As of May 07, 2026 Zimmer Biomet Holdings has a market cap of $ 17 B
Capitalization is the market value of a company whose shares are traded on the stock exchange. It is calculated by multiplying the market price of a share by the total number of the company's shares. Capitalization indicates volatility, risk, and growth potential. This metric is often used for a quick assessment of a company’s investment profile.[1]
Capitalization is an important indicator for investors and analysts, as it helps determine the size and significance of a company in the stock market. Companies with large capitalization are considered more stable and reliable, as they have more resources and financial power to grow and survive in the market.
This metric can be divided into several categories: small (from 300 million to 2 billion dollars), medium (from 2 to 10 billion dollars), and large (over 10 billion dollars). Companies with different levels of capitalization have their own characteristics and risks, so investors usually take this indicator into account when making investment decisions.
Capitalization can also change over time depending on the share price and the number of shares in circulation. Therefore, it is a dynamic indicator that requires constant monitoring and analysis to make well-informed investment decisions.
Annual Market Cap Zimmer Biomet Holdings
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 21.8 B | 26.9 B | 25.7 B | 25.7 B | 30.7 B | 31 B | 22.1 B | 25.4 B | 23.1 B | 18.6 B | 18.9 B | 15.8 B | 13 B | 11.4 B |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 31 B | 11.4 B | 22.2 B |
References
- Pavone, P. (2019). Market capitalization and financial variables: Evidence from Italian listed companies. International Journal of Academic Research Business and Social Sciences, 9(3), 1356-1371.
Market Cap of other stocks in the Medical devices industry
| Issuer | Market Cap | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Helius Medical Technologies
HSDT
|
3.54 M | $ 2.2 | -0.9 % | $ 1.34 M |  USA |
 |
OrthoPediatrics Corp.
KIDS
|
437 M | $ 17.5 | 2.19 % | $ 411 M | USA |
 |
GenMark Diagnostics, Inc.
GNMK
|
933 M | - | - | $ 1.77 B | USA |
 |
LENSAR
LNSR
|
71.3 M | $ 5.41 | 0.46 % | $ 64.7 M | USA |
 |
Lianluo Smart Limited
LLIT
|
147 M | - | 24.59 % | $ 44.8 M |  China |
 |
Allied Healthcare Products
AHPI
|
4.01 M | - | 3.58 % | $ 2.21 M | USA |
 |
Obalon Therapeutics, Inc.
OBLN
|
35 M | - | -5.86 % | $ 30.6 M | USA |
 |
Apollo Endosurgery
APEN
|
403 M | - | - | $ 475 M | USA |
 |
Alphatec Holdings
ATEC
|
2.07 B | $ 7.72 | 10.44 % | $ 1.16 B | USA |
 |
EDAP TMS S.A.
EDAP
|
139 M | $ 4.25 | 18.22 % | $ 159 M |  France |
 |
Orthofix Medical
OFIX
|
491 M | $ 12.29 | 0.82 % | $ 487 M |  Curacao |
 |
Aziyo Biologics
AZYO
|
26.9 M | - | 1.37 % | $ 20.5 M | USA |
 |
Avinger
AVGR
|
2.59 M | - | -20.74 % | $ 369 K | USA |
 |
Axonics Modulation Technologies
AXNX
|
2.82 B | - | - | $ 3.31 B | USA |
 |
Insulet Corporation
PODD
|
18.1 B | $ 160.88 | 6.35 % | $ 11.3 B | USA |
 |
BioSig Technologies
BSGM
|
7.3 M | - | 37.08 % | $ 85.7 M | USA |
 |
BIOLASE
BIOL
|
192 K | - | -13.19 % | $ 166 K | USA |
 |
Sintx Technologies
SINT
|
6.91 M | $ 2.5 | 4.26 % | $ 6.93 M | USA |
 |
Conformis
CFMS
|
12.6 M | - | - | $ 16.4 M | USA |
 |
ClearPoint Neuro
CLPT
|
316 M | $ 11.75 | 2.44 % | $ 333 M | USA |
 |
Cardiovascular Systems
CSII
|
588 M | - | 0.15 % | $ 844 M | USA |
 |
CryoLife, Inc.
CRY
|
906 M | - | -4.14 % | $ 702 M | USA |
 |
Stryker Corporation
SYK
|
147 B | $ 297.41 | 1.74 % | $ 114 B | USA |
 |
CHF Solutions, Inc.
CHFS
|
1.05 M | - | 1.15 % | $ 34.5 M | USA |
 |
Cytosorbents Corporation
CTSO
|
34.8 M | $ 0.59 | 3.51 % | $ 36.7 M | USA |
 |
LivaNova PLC
LIVN
|
3.81 B | $ 69.21 | 4.44 % | $ 3.78 B |  Britain |
 |
Delcath Systems
DCTH
|
326 M | $ 11.4 | 1.24 % | $ 408 M | USA |
 |
Soliton, Inc.
SOLY
|
229 M | - | -1.42 % | $ 435 M | USA |
 |
Tandem Diabetes Care
TNDM
|
1.26 B | $ 18.3 | 1.5 % | $ 1.24 B | USA |
 |
Hancock Jaffe Laboratories, Inc.
HJLI
|
7.99 M | - | -1.98 % | $ 98.3 M | USA |
 |
Itamar Medical Ltd.
ITMR
|
339 M | - | 0.03 % | $ 1.58 B |  Israel |
 |
Misonix, Inc.
MSON
|
185 M | - | - | $ 462 M | USA |
 |
Neovasc
NVCN
|
677 M | - | - | $ 111 M |  Canada |
 |
IRIDEX Corporation
IRIX
|
16.6 M | $ 1.04 | 0.19 % | $ 17.6 M | USA |
 |
Dynatronics Corporation
DYNT
|
1.95 M | - | 14.99 % | $ 929 K | USA |
 |
Eargo
EAR
|
17 M | - | - | $ 10.2 M | USA |
 |
Myomo
MYO
|
33.9 M | $ 0.88 | 3.17 % | $ 36.8 M | USA |
 |
Electromed
ELMD
|
175 M | $ 26.74 | 3.06 % | $ 226 M | USA |
 |
Butterfly Network
BFLY
|
766 M | $ 4.41 | -3.08 % | $ 934 M | USA |
 |
Intersect ENT, Inc.
XENT
|
735 M | - | - | $ 955 M | USA |
 |
Second Sight Medical Products
EYES
|
225 M | - | -0.97 % | $ 54.4 M | USA |
 |
GBS
GBS
|
2.48 M | - | -0.57 % | $ 7.12 M | USA |
 |
Globus Medical
GMED
|
12.5 B | $ 89.66 | 0.49 % | $ 12.1 B | USA |
 |
Varex Imaging Corporation
VREX
|
502 M | $ 12.21 | 0.33 % | $ 505 M | USA |
 |
CONMED Corporation
CNMD
|
1.32 B | $ 38.29 | 2.6 % | $ 1.19 B | USA |
 |
Inspire Medical Systems
INSP
|
1.76 B | $ 47.05 | 2.95 % | $ 1.38 B | USA |
 |
Integer Holdings Corporation
ITGR
|
2.98 B | $ 88.37 | 2.41 % | $ 3.07 B | USA |
 |
Invacare Corporation
IVC
|
24.1 M | - | - | $ 24.7 M | USA |
 |
Edwards Lifesciences Corporation
EW
|
48.8 B | $ 83.92 | 0.87 % | $ 49.1 B | USA |
 |
Tactile Systems Technology
TCMD
|
640 M | $ 26.67 | 5.42 % | $ 610 M | USA |